Crescent Biopharma, Inc. Capital Reinvestment Ratio
Crescent Biopharma, Inc. capital reinvestment ratio. Crescent Biopharma, Inc. (CBIO) has a Capital Reinvestment Ratio of 0.00x as of September 2015, meaning it reinvests 0% of its operating cash flow ($13.56 Million) in capital expenditures ($58.39K). Check CBIO total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Crescent Biopharma, Inc. (2011–2011)
Capital reinvestment ratio of Crescent Biopharma, Inc. from 2011 to 2011. This chart tracks Crescent Biopharma, Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore Crescent Biopharma, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Crescent Biopharma, Inc. Capital Reinvestment Ratio by Year (2011–2011)
Crescent Biopharma, Inc. capital reinvestment ratio by year from 2011 to 2011. For the full cash flow conversion analysis, see cash efficiency ratio of Crescent Biopharma, Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.01x | $13.85 Million | $182.44K | — |